NCT03665922已完成不适用
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 39
- 试验地点
- 2
- 主要终点
- Palmitic Acid Reduction
研究概览
简要总结
This study will test whether oral intake of a dietary supplement called BroccoMax®, which is a special blend of broccoli extract containing a chemical called sulforaphane (hereafter abbreviated as SFN), may result in changes in chemicals that feed prostate cancer. BroccoMax® is available over the counter.
详细描述
Eligible subjects will be randomly assigned to either BroccoMax® or placebo arm with a 1:1 randomization. Each subject will be given BroccoMax® equivalent to 4 weeks supply. Following randomization, subjects will begin to take four study tablets (BroccoMax® or placebo) in the morning with breakfast and four tablets in the evening with dinner. The eight BroccoMax® tablets will provide a daily internal dose of 64 mg of SFN.
Baseline evaluation will be 28 days before scheduled prostatectomy, the same day of study drug dispensation, and will include.
- Data collection on patient's medical history (which includes age, cancer history, review of medications, food intolerances and food habits), and concomitant medications.
- Physical exam including height and weight measurements.
- Blood (approximately 15 mL) will be collected in Serum Separator Tube-tiger tubes (SST)for determination of SFN and its metabolite levels and for biomarker analyses.
- Spot urine collection (15 mL) for measuring SFN and its metabolite levels.
- Four-week supply of study drug (BroccoMax® or Placebo) dispensation
Day 28 ± 3 days (End of study evaluation)
- Physical exam including height and weight measurements
- Blood (approximately 15 mL) will be collected in SST-tiger tubes for determination of SFN and its metabolite levels and for biomarker analyses.
- Spot urine collection (15 mL) for measuring SFN and its metabolite levels.
- Adverse event assessment.
- A portion of the prostate tumor after surgical resection will be fresh frozen in liquid nitrogen.
- After pathological assessment is complete, tumor blocks or slides (6 or more) will be requested by the clinical research coordinator from the Health Sciences Tissue Bank of the University of Pittsburgh for biomarker analyses.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Men ≥ 18 years of age scheduled to undergo radical prostatectomy as standard of care for a diagnosis of prostate adenocarcinoma.
- •Subjects willing to take oral placebo or BroccoMax® pills (4 capsules twice daily after breakfast and dinner) on a daily basis for 4 weeks prior to prostatectomy. Subjects have the ability to swallow BroccoMax® or placebo pills.
- •Subjects in good health per investigator evaluation with liver enzyme and blood count values within the following ranges:
- •White blood cells ≥ 3,000/mL Total bilirubin ≤ 1.5 x Upper Limits of Normal (ULN) Aspartate Aminotransferase (AST (SGOT))/ Alanine Aminotransferase (ALT (SGPT)) ≤ 2.5 x ULN Blood Urea Nitrogen (BUN) and serum creatinine ≤ 1.5 x ULN
- •Subjects willing to abstain from dietary sources of glucosinolates and isothiocyanates (see Appendix) for the duration of the study (4 weeks)
- •Subjects must be fully informed of the investigational nature of this study and must sign a written informed consent in accordance within institutional and regulatory guidelines
排除标准
- •Subjects ineligible to undergo prostatectomy due to co-morbidities.
- •Subjects with a second malignancy or any other cancer at least 3 years following definitive treatment with no evidence of disease, except for adequately treated basal cell or squamous cell skin cancer.
- •Subjects with malabsorption issues or gastrointestinal ailments than can interfere with the ability to adequately absorb SFN.
- •Subjects with prior or concurrent androgen deprivation therapy with Luteinizing hormone-releasing hormone (LHRH) agonist or antagonists
- •Subjects taking any other investigational agent, dietary supplement or herbal supplement or participating in clinical studies involving investigational agents
- •Subjects with clinically significant comorbid diseases including active infection, uncontrolled angina, New York Heart Assoc. (NYHA) class III or IV heart failure, uncontrolled or uncontrollable hypertension, severe diabetes with complications, chronic liver disease.
- •Subjects with prior history of known intolerance or allergic reactions attributed to cruciferous vegetables or specific fillers used in the placebo.
结局指标
主要结局
Palmitic Acid Reduction
时间窗: 4 weeks
Change in serum levels of palmitic acid (the primary free fatty acid) in subjects treated with BroccoMax® compared to placebo.
次要结局
- Prostate adenocarcinoma SFN level(Week 4)
- Serum SFN levels(4 weeks)
- Evaluation of Prostate adenocarcinoma tissue by immunohistochemistry.(Week 4)
- Mean proliferative index (Ki-67) and apoptotic marker (TUNEL) in prostate adenocarcinoma sections(Week 4)
- Evaluation of safety of BroccoMax® (side effects or adverse events)(2 months)
- Urine SFN levels(4 weeks)
- Evaluation of serum levels of fatty acid metabolism intermediates.(Weeks 2 and 4.)
- Evaluation of prostate adenocarcinoma levels of fatty acid metabolism intermediates(Week 4)
研究者
Bruce Jacobs
Univ of P. Physicians Faculty
University of Pittsburgh
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Effect of Broccoli Sprout Extract in Patients With Chronic Kidney Disease With Diabetes Type 2Chronic Kidney Disease Stage 3BChronic Kidney Disease stage4Diabetes Mellitus, Type 2NCT04858854Karolinska Institutet100
已完成
1 期
Effects of Sulforaphane on Normal Prostate TissueProstate CancerNCT00946309Fred Hutchinson Cancer Center45
已完成
2 期
Sulforaphane-rich Broccoli Sprout Extract for AutismAutismNCT01474993Andrew Zimmerman44
已完成
不适用
Broccoli In OsteoarthritisOsteoarthritisNCT03878368University of East Anglia24
进行中（未招募）
不适用
Effect of L. Plantarum Probiotic Supplementation on Broccoli Sulforaphane Bioavailability: Randomised Double-blind Placebo-controlled Crossover StudyNutrition, HealthyNCT06561893University of Exeter12